NZ223400A - Dental composition containing kappa-caseino-glycopeptides - Google Patents

Dental composition containing kappa-caseino-glycopeptides

Info

Publication number
NZ223400A
NZ223400A NZ223400A NZ22340088A NZ223400A NZ 223400 A NZ223400 A NZ 223400A NZ 223400 A NZ223400 A NZ 223400A NZ 22340088 A NZ22340088 A NZ 22340088A NZ 223400 A NZ223400 A NZ 223400A
Authority
NZ
New Zealand
Prior art keywords
caseino
glycopeptides
composition containing
dental composition
containing kappa
Prior art date
Application number
NZ223400A
Other languages
English (en)
Inventor
Jean-Richard Neeser
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of NZ223400A publication Critical patent/NZ223400A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
    • A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
    • A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A23G3/366—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing microorganisms, enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
    • A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
    • A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A23G3/368—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing vitamins, antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
    • A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
    • A23G3/44—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
    • A23G4/12—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A23G4/123—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing microorganisms, enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Birds (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Massaging Devices (AREA)
  • Percussion Or Vibration Massage (AREA)
NZ223400A 1987-02-26 1988-02-03 Dental composition containing kappa-caseino-glycopeptides NZ223400A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH732/87A CH671879A5 (enExample) 1987-02-26 1987-02-26

Publications (1)

Publication Number Publication Date
NZ223400A true NZ223400A (en) 1990-08-28

Family

ID=4193901

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ223400A NZ223400A (en) 1987-02-26 1988-02-03 Dental composition containing kappa-caseino-glycopeptides

Country Status (10)

Country Link
US (2) US4994441A (enExample)
EP (1) EP0283675B1 (enExample)
JP (1) JP2760429B2 (enExample)
AT (1) ATE86475T1 (enExample)
CH (1) CH671879A5 (enExample)
DE (1) DE3878951T2 (enExample)
ES (1) ES2039484T3 (enExample)
FI (1) FI88578C (enExample)
NZ (1) NZ223400A (enExample)
ZA (1) ZA88798B (enExample)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5344820A (en) * 1987-05-15 1994-09-06 Snow Brand Milk Products Co., Ltd. Infection protectant
JP2631470B2 (ja) * 1987-05-15 1997-07-16 雪印乳業株式会社 感染防御剤
US5324653A (en) * 1988-02-11 1994-06-28 Gist-Brocades N.V. Recombinant genetic means for the production of serine protease muteins
JP2673828B2 (ja) * 1989-04-19 1997-11-05 雪印乳業株式会社 κ―カゼイングリコマクロペプチドの製造法
FR2646775A1 (fr) * 1989-05-11 1990-11-16 Centre Nat Rech Scient Utilisation du caseinoglycopeptide k, notamment de lait de vache, pour la fabrication d'une composition, notamment d'un medicament, pour la prevention et le traitement des thromboses
CH681543A5 (enExample) * 1990-04-27 1993-04-15 Nestle Sa
US5326752A (en) * 1991-11-27 1994-07-05 Glycomed Incorporated Substituted lactose and lactosamine derivatives as cell adhesion inhibitors
US5362480A (en) * 1991-12-31 1994-11-08 Lever Brothers Company, Division Of Conopco, Inc. Oral hygiene compositions containing amino sugars as antiplaque agents
US5409902A (en) * 1991-12-31 1995-04-25 Lever Brothers Company Oral hygiene compositions containing glyceroglycolipids as antiplaque compounds
US5310542A (en) * 1991-12-31 1994-05-10 Lever Brothers Company, Division Of Conopco, Inc. Oral hygiene compositions containing antiplaque agents
US5591835A (en) * 1992-06-29 1997-01-07 Glycomed Incorporated Substituted lactose derivatives
CO4560537A1 (es) * 1992-12-28 1998-02-10 Nestle Sa Composicion lactea y procedimiento de preparacion
CH684773A5 (fr) * 1992-12-28 1994-12-30 Nestle Sa Composition alimentaire anti-cariogène.
US5320830A (en) * 1992-12-30 1994-06-14 The Procter & Gamble Company Oral compositions
US5320831A (en) * 1992-12-30 1994-06-14 The Procter & Gamble Company Oral compositions
US5416075A (en) * 1993-11-30 1995-05-16 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Biospecific emulsions
US5560905A (en) * 1994-05-13 1996-10-01 The Proctor & Gamble Company Oral compositions
US5578294A (en) * 1994-05-13 1996-11-26 The Procter & Gamble Company Oral compositions
US5849271A (en) * 1995-06-07 1998-12-15 The Procter & Gamble Company Oral compositions
EP0748591B1 (fr) 1995-06-16 2001-10-17 Societe Des Produits Nestle S.A. Caséines micellaires fluorées
US5741773A (en) * 1996-04-26 1998-04-21 Colgate Palmolive Company Storage stable dentifrice composition containing an antibacterial casein glycomacropeptide adjuvant
JP2001525853A (ja) * 1997-05-19 2001-12-11 コルゲート・パーモリブ・カンパニー フッ化物を用いない歯の再石灰化
US5853704A (en) * 1997-09-22 1998-12-29 Colgate-Palmolive Company Fluoride dentifrices of enhanced efficacy
AUPP051497A0 (en) * 1997-11-24 1997-12-18 University Of Melbourne, The Antimicrobial peptides
AU756347B2 (en) * 1997-11-24 2003-01-09 Dairy Australia Limited Antimicrobial peptides
DE69804850T2 (de) 1997-12-11 2002-08-22 Arla Foods Amba, Viby J Verfahren zur herstellung eines kappa-casein-glykomakropeptides oder eines abkoemmlings davon
AUPP494798A0 (en) 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
AU752977B2 (en) * 1998-08-07 2002-10-03 Societe Des Produits Nestle S.A. Anti-cariogenic milk product and use
AU773799B2 (en) * 1998-08-12 2004-06-10 Societe Des Produits Nestle S.A. Incorporation of exogenous lactic bacteria into the oral microflora
EP1159951A1 (en) * 2000-06-02 2001-12-05 Societe Des Produits Nestle S.A. Use of exogenous lactic bacteria strain against Actinomyces naeslundii-related diseases
EP1062876A1 (en) * 1999-02-25 2000-12-27 Societe Des Produits Nestle S.A. Caseinoglycomacropeptides as calcification agent
GB9927603D0 (en) * 1999-11-22 2000-01-19 Nestle Sa Use of a milk protein hydrolysate in the treatment of diabetes
DE60029637T2 (de) 2000-01-27 2007-07-26 Fonterra Tech Ltd. Kaugummigrundstoff
EP1151673A3 (en) * 2000-05-03 2002-01-02 Societe Des Produits Nestle S.A. Confectionery product having a filling
ATE339217T1 (de) * 2000-07-14 2006-10-15 Nestle Sa Caseinoglycomacropeptide zur inhibierung der adhäsion von pathogener flora auf der haut
WO2002078462A1 (en) * 2001-03-30 2002-10-10 Societe Des Produits Nestle S.A. Methods and products for removing tartar from the teeth of a pet
US6482396B1 (en) 2001-05-15 2002-11-19 Campina Melkunie B.V. Methods for treating or preventing diseases of the oral cavity
AU2002345773A1 (en) * 2001-06-08 2002-12-23 Societe Des Produits Nestle S.A. Sugar-based composition containing caseinoglycomacropeptide
US20040101494A1 (en) 2002-11-26 2004-05-27 Scott Douglas Craig Chewable solid unit dosage forms and methods for delivery of active agents into occlusal surfaces of teeth
US7354569B2 (en) * 2003-07-11 2008-04-08 Colgate-Palmolive Company Chewable antiplaque confectionery dental composition
US20050123490A1 (en) * 2003-12-04 2005-06-09 Kazue Yamagishi Composition and method for prevention and treatment of dental caries
CA2550581C (en) * 2003-12-19 2013-04-16 The University Of Melbourne Antimicrobial composition comprising a peptide derived from k-casein and a divalent cation
US20070122357A1 (en) * 2005-11-29 2007-05-31 The Procter & Gamble Company Dentifrice composition
WO2007095374A2 (en) * 2006-02-14 2007-08-23 Mastertaste Inc. Antimicrobial smoke flavor for oral microflora control
US8765155B2 (en) * 2007-08-30 2014-07-01 Colgate-Palmolive Company Oral care strip or tape and methods of use and manufacture thereof
AU2008303851A1 (en) * 2007-09-11 2009-04-02 Mondobiotech Laboratories Ag Use of the peptides MAIPPKKNQDK (cow kappa casein 106-116) and/or YGFQNA (serorphin) as therapeutic agents
US20110052509A1 (en) 2008-02-08 2011-03-03 Colgate-Palmolive Company Compositions comprising basic amino acid and soluble carbonate salt
EP2249792A4 (en) 2008-02-08 2014-01-08 Colgate Palmolive Co MOUTHPACKAGE PRODUCT AND METHOD OF PREPARATION AND MANUFACTURE THEREFOR
JP2011515332A (ja) 2008-02-08 2011-05-19 コルゲート・パーモリブ・カンパニー 口腔ケア製品ならびにそれを使用および製造する方法
JP2011510683A (ja) * 2008-02-08 2011-04-07 コルゲート・パーモリブ・カンパニー 口腔ケア法及びシステム
PE20091668A1 (es) * 2008-02-08 2009-11-04 Colgate Palmolive Co Nuevas sales y sus usos
JP2011511091A (ja) 2008-02-08 2011-04-07 コルゲート・パーモリブ・カンパニー 塩基性アミノ酸のペプチドおよびプロテアーゼを含む組成物および方法
JP2011511093A (ja) 2008-02-08 2011-04-07 コルゲート・パーモリブ・カンパニー 口腔ケア製品およびその使用方法
AU2008349850B2 (en) 2008-02-08 2011-10-20 Colgate-Palmolive Company Oral care product and methods of use and manufacture thereof
RU2491928C1 (ru) * 2008-02-08 2013-09-10 Колгейт-Палмолив Компани Искусственная слюна, содержащая аминокислоту и применение основной аминокислоты для лечения сухости во рту
BRPI0912655A2 (pt) 2008-05-16 2019-09-17 Colgate Palmolive Co composição oral, e, método para melhorar a saúde oral
US9724278B2 (en) * 2008-06-13 2017-08-08 Colgate-Palmolive Company Oral compositions and uses thereof
US7954996B2 (en) * 2008-07-08 2011-06-07 General Electric Company Positioning system with tilting arm support for imaging devices
TWI404544B (zh) 2008-08-11 2013-08-11 Colgate Palmolive Co 含珠粒之口腔保健組成物
RU2011144353A (ru) 2009-04-02 2013-05-10 Колгейт-Палмолив Компани Композиции по уходу за полостью рта, содержащие тетракалий пирофосфат
AU2009343766B2 (en) 2009-04-02 2013-02-14 Colgate-Palmolive Company Color changing consumer products
EP2419445A2 (en) 2009-04-16 2012-02-22 Forsyth Dental Infirmary for Children New methods of making an antibody and compositions thereof
JP2013510799A (ja) * 2009-11-11 2013-03-28 オーラル ヘルス オーストラリア ピーティーワイ リミテッド 抗バイオフィルム糖ペプチド
TR201802987T4 (tr) * 2010-02-03 2018-03-21 Dsm Ip Assets Bv Süt teknolojisinde siyalidaz kullanımı.
PH12012502464A1 (en) 2010-06-23 2016-12-16 Colgate Palmolive Co Therapeutic oral composition
CN103153267B (zh) 2010-08-18 2015-07-22 高露洁-棕榄公司 口腔护理产品及其使用和制备方法
US8383582B2 (en) * 2010-09-23 2013-02-26 Industry Foundation Of Chonnam National University Inhibitor against forming biofilm comprising κ-casein macropeptide
US20130224270A1 (en) 2010-10-27 2013-08-29 Colgate-Palmolive Company Oral Care Composition Comprising Arginine and Calcium Carbonate
MX347095B (es) 2010-11-08 2017-04-12 Colgate Palmolive Co Composiciones orales que contienen microagregados.
CN107252396A (zh) 2010-11-12 2017-10-17 高露洁-棕榄公司 口腔护理产品及其使用和制备方法
MX344840B (es) 2010-11-12 2017-01-09 Colgate Palmolive Co Producto de cuidado oral y metodos de uso y fabricación de los mismos.
SG189434A1 (en) 2010-11-12 2013-06-28 Colgate Palmolive Co Oral care product and methods of use and manufacture thereof
US9717929B2 (en) 2010-12-07 2017-08-01 Colgate-Palmolive Company Dentifrice compositions containing calcium silicate and a basic amino acid
MX345847B (es) 2011-12-15 2017-02-20 Colgate Palmolive Co Composiciones para el cuidado oral.
RU2593800C2 (ru) 2011-12-16 2016-08-10 Колгейт-Палмолив Компани Меняющие цвет композиции
EP2700396A3 (en) 2012-06-20 2015-04-29 Sylphar Nv Strip for the delivery of oral care compositions
PL2908798T3 (pl) 2012-10-17 2019-02-28 Procter & Gamble Pasek do wprowadzania środka aktywującego higienę jamy ustnej i sposoby stosowania środków aktywujących higienę jamy ustnej
US20150210964A1 (en) 2014-01-24 2015-07-30 The Procter & Gamble Company Consumer Product Compositions
BR112019012551B1 (pt) 2016-12-27 2022-11-01 Colgate-Palmolive Company Enxaguante bucal bifásico
CN111032870A (zh) 2017-08-09 2020-04-17 宝洁公司 用于口腔护理应用的适配体
US11172873B2 (en) 2018-05-17 2021-11-16 The Procter & Gamble Company Systems and methods for hair analysis
EP3793427A1 (en) 2018-05-17 2021-03-24 The Procter & Gamble Company Systems and methods for hair coverage analysis
CN112771164A (zh) 2018-06-29 2021-05-07 宝洁公司 用于个人护理应用的适配体
CA3134598A1 (en) 2019-03-29 2020-10-08 Colgate-Palmolive Company Oral care product
BR112021018667A2 (pt) 2019-03-29 2021-11-23 Colgate Palmolive Co Produto para higiene bucal e métodos para utilização e fabricação do mesmo
WO2020214784A1 (en) 2019-04-16 2020-10-22 The Procter & Gamble Company Aptamers for odor control applications
AU2020397192B2 (en) 2019-12-06 2024-02-15 Colgate-Palmolive Company Oral care product and methods of use and manufacture thereof
EP4021585A1 (en) 2020-03-27 2022-07-06 Colgate-Palmolive Company Oral care compositions and methods of use
WO2021195590A1 (en) 2020-03-27 2021-09-30 Colgate-Palmolive Company Oral care compositions and methods of use
WO2022026672A1 (en) 2020-07-31 2022-02-03 Colgate-Palmolive Company Process for producing an oral care composition
US12039732B2 (en) 2021-04-14 2024-07-16 The Procter & Gamble Company Digital imaging and learning systems and methods for analyzing pixel data of a scalp region of a users scalp to generate one or more user-specific scalp classifications
CA3231150A1 (en) 2021-09-23 2023-03-30 Carlo DAEP Oral care compositions and methods of use

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2154168A (en) * 1936-12-29 1939-04-11 Klein Henry Dentifrice
FR1580913A (enExample) * 1968-04-19 1969-09-12
FR2288477A1 (fr) * 1974-10-22 1976-05-21 Manche Union Coop Agr Laiti Procede de production d'acide sialique et de glycoproteines a partir de lactoserum de fromagerie
FR2288473A1 (fr) * 1974-10-22 1976-05-21 Manche Union Coop Agr Laiti Procede de traitement du lactoserum de fromagerie, notamment en vue de l'extraction de glycoproteides et d'acide sialique
US4151271A (en) * 1976-11-01 1979-04-24 Monsanto Company Oral compositions
DE2718325C2 (de) * 1977-04-25 1986-09-25 Behringwerke Ag, 3550 Marburg Leucinreiches 3,1-S-α↓2↓-Glykoprotein sowie dessen Verwendung
FR2425809A1 (fr) * 1978-05-18 1979-12-14 Beatrice Foods Co Precipite colloidal de petit-lait et composition alimentaire le contenant
FR2459619B1 (fr) * 1979-06-26 1983-07-29 Agronomique Inst Nat Rech Procede pour l'obtention a partir de lactoserum, d'un produit enrichi en alpha-lactalbumine et applications dudit procede
FR2474829B1 (fr) * 1980-02-01 1983-09-09 Agronomique Inst Nat Rech Procede de traitement d'une matiere a base de caseine contenant des phosphocaseinates de cations monovalents ou leurs derives, produits obtenus et applications
ATE73668T1 (de) * 1983-12-22 1992-04-15 Univ Melbourne Karieshemmung.
US4579736A (en) * 1984-03-13 1986-04-01 Colgate-Palmolive Co. Inhibition of plaque-forming bacteria

Also Published As

Publication number Publication date
ATE86475T1 (de) 1993-03-15
JP2760429B2 (ja) 1998-05-28
FI880464A0 (fi) 1988-02-02
CH671879A5 (enExample) 1989-10-13
JPS63233911A (ja) 1988-09-29
DE3878951D1 (de) 1993-04-15
ES2039484T3 (es) 1993-10-01
FI88578C (fi) 1993-06-10
EP0283675A3 (en) 1989-04-26
ZA88798B (en) 1988-08-04
US4994441A (en) 1991-02-19
EP0283675A2 (fr) 1988-09-28
FI88578B (fi) 1993-02-26
FI880464L (fi) 1988-08-27
US4992420A (en) 1991-02-12
EP0283675B1 (fr) 1993-03-10
DE3878951T2 (de) 1993-09-16

Similar Documents

Publication Publication Date Title
NZ223400A (en) Dental composition containing kappa-caseino-glycopeptides
ID29393A (id) Komposisi pengobatan kanker dan metoda penggunaan minyak-minyak esensil tanaman alamiah
PT83902B (en) Inhibition of the 5-lipoxygenase pathway
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
MY100641A (en) Neutral metalloendopeptidase inhibitors in the treatment of hypertension.
EP0209689A3 (en) Use of tetrahydrobiopterins in the treatment of infantile autism
MY129189A (en) Prostaglandin agonists and their use to treat bone disorders
BR9507752A (pt) Cepas de lactobacilos de origem humanan suas composições e seus usos
EP0374440A3 (en) Inhibitors of lysyl oxidase
UA41355C2 (uk) Засіб для лікування нейро-сніду
MY129293A (en) The use of mmp-13 selective inhibitors for the treatment of osteoarthristis and other mmp-mediated disorders
EP0705100A4 (en) THERAPEUTIC SUBSTITUTED GUANIDINES
SG48298A1 (en) Saccharin deriatives useful as proteolytic enzymeinhibitors and preparation of
PL328412A1 (en) Derivatives of benzamidine substituted with derivatives of amino acid and hydroxy acid as well as their application as antithrombotic agents
IL141686A0 (en) Methods of treating hypertension and compositions for use therein
PL316656A1 (en) Free halophantrin base for use in treating marsh-fever and compositions containing same
MD960168A (ro) Metodă şi compuşi pentru tratamentul infecţiilor virale
HUT66153A (en) Pharmaceutical compositions which can be used for preventing and treating of chemotherapy-induced alopecia
BG102716A (en) Method for the treatment of cardiac insufficiency by means of formulations opposing the endotheline
ES2089177T3 (es) Nuevos peptidos inhibidores.
AU1541088A (en) Composition for the treatment of the epiderm
NZ514027A (en) Cloning and expression of haemophilus somnus transferrin-binding proteins
BG103859A (en) The use of 1-ar(alk)yl-imidazolin-2-on for the treatment of fear and stress conditions
SG44827A1 (en) Compounds useful as antiproliferative agents and garft inhibitors
GB9015774D0 (en) Novel treatment